These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 28198708)
1. Dystroglycanopathies: About Numerous Genes Involved in Glycosylation of One Single Glycoprotein. Bouchet-Séraphin C; Vuillaumier-Barrot S; Seta N J Neuromuscul Dis; 2015; 2(1):27-38. PubMed ID: 28198708 [TBL] [Abstract][Full Text] [Related]
2. 160 kb deletion in ISPD unmasking a recessive mutation in a patient with Walker-Warburg syndrome. Czeschik JC; Hehr U; Hartmann B; Lüdecke HJ; Rosenbaum T; Schweiger B; Wieczorek D Eur J Med Genet; 2013 Dec; 56(12):689-94. PubMed ID: 24120487 [TBL] [Abstract][Full Text] [Related]
3. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Godfrey C; Clement E; Mein R; Brockington M; Smith J; Talim B; Straub V; Robb S; Quinlivan R; Feng L; Jimenez-Mallebrera C; Mercuri E; Manzur AY; Kinali M; Torelli S; Brown SC; Sewry CA; Bushby K; Topaloglu H; North K; Abbs S; Muntoni F Brain; 2007 Oct; 130(Pt 10):2725-35. PubMed ID: 17878207 [TBL] [Abstract][Full Text] [Related]
4. [Recent advances in congenital muscular dystrophy research]. Nonaka I No To Hattatsu; 2005 Mar; 37(2):115-21. PubMed ID: 15773323 [TBL] [Abstract][Full Text] [Related]
5. [Fukuyama congenital muscular dystrophy and related alpha-dystroglycanopathies]. Murakami T; Nishino I Brain Nerve; 2008 Oct; 60(10):1159-64. PubMed ID: 18975603 [TBL] [Abstract][Full Text] [Related]
6. POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome. van Reeuwijk J; Janssen M; van den Elzen C; Beltran-Valero de Bernabé D; Sabatelli P; Merlini L; Boon M; Scheffer H; Brockington M; Muntoni F; Huynen MA; Verrips A; Walsh CA; Barth PG; Brunner HG; van Bokhoven H J Med Genet; 2005 Dec; 42(12):907-12. PubMed ID: 15894594 [TBL] [Abstract][Full Text] [Related]
7. Glycosylation defects: a new mechanism for muscular dystrophy? Grewal PK; Hewitt JE Hum Mol Genet; 2003 Oct; 12 Spec No 2():R259-64. PubMed ID: 12925572 [TBL] [Abstract][Full Text] [Related]
8. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Longman C; Brockington M; Torelli S; Jimenez-Mallebrera C; Kennedy C; Khalil N; Feng L; Saran RK; Voit T; Merlini L; Sewry CA; Brown SC; Muntoni F Hum Mol Genet; 2003 Nov; 12(21):2853-61. PubMed ID: 12966029 [TBL] [Abstract][Full Text] [Related]
9. Clinical long-time course, novel mutations and genotype-phenotype correlation in a cohort of 27 families with POMT1-related disorders. Geis T; Rödl T; Topaloğlu H; Balci-Hayta B; Hinreiner S; Müller-Felber W; Schoser B; Mehraein Y; Hübner A; Zirn B; Hoopmann M; Reutter H; Mowat D; Schuierer G; Schara U; Hehr U; Kölbel H Orphanet J Rare Dis; 2019 Jul; 14(1):179. PubMed ID: 31311558 [TBL] [Abstract][Full Text] [Related]
11. Muscular dystrophies due to glycosylation defects. Muntoni F; Torelli S; Brockington M Neurotherapeutics; 2008 Oct; 5(4):627-32. PubMed ID: 19019316 [TBL] [Abstract][Full Text] [Related]
12. Mechanistic aspects of the formation of α-dystroglycan and therapeutic research for the treatment of α-dystroglycanopathy: A review. Taniguchi-Ikeda M; Morioka I; Iijima K; Toda T Mol Aspects Med; 2016 Oct; 51():115-24. PubMed ID: 27421908 [TBL] [Abstract][Full Text] [Related]
13. Broad spectrum of phenotype and genotype in Korean α-dystroglycan related muscular dystrophy presenting to a tertiary pediatric neuromuscular center. Ko YJ; Cho A; Kim WJ; Kim SY; Lim BC; Kim H; Hwang H; Choi JE; Kim KJ; Chae JH Neuromuscul Disord; 2023 May; 33(5):425-431. PubMed ID: 37087885 [TBL] [Abstract][Full Text] [Related]
14. POMGnT1, POMT1, and POMT2 mutations in congenital muscular dystrophies. Endo T; Manya H; Seta N; Guicheney P Methods Enzymol; 2010; 479():343-52. PubMed ID: 20816175 [TBL] [Abstract][Full Text] [Related]
15. [Alpha-dystroglycanopathy (FCMD, MEB, etc): abnormal glycosylation and muscular dystrophy]. Toda T Rinsho Shinkeigaku; 2005 Nov; 45(11):932-4. PubMed ID: 16447766 [TBL] [Abstract][Full Text] [Related]
16. Intragenic rearrangements in LARGE and POMGNT1 genes in severe dystroglycanopathies. Vuillaumier-Barrot S; Bouchet-Seraphin C; Chelbi M; Eude-Caye A; Charluteau E; Besson C; Quentin S; Devisme L; Le Bizec C; Landrieu P; Goldenberg A; Maincent K; Loget P; Boute O; Gilbert-Dussardier B; Encha-Razavi F; Gonzales M; Grandchamp B; Seta N Neuromuscul Disord; 2011 Nov; 21(11):782-90. PubMed ID: 21727005 [TBL] [Abstract][Full Text] [Related]
17. Missense mutations in β-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) cause Walker-Warburg syndrome. Buysse K; Riemersma M; Powell G; van Reeuwijk J; Chitayat D; Roscioli T; Kamsteeg EJ; van den Elzen C; van Beusekom E; Blaser S; Babul-Hirji R; Halliday W; Wright GJ; Stemple DL; Lin YY; Lefeber DJ; van Bokhoven H Hum Mol Genet; 2013 May; 22(9):1746-54. PubMed ID: 23359570 [TBL] [Abstract][Full Text] [Related]
18. [Recent Advances in α-dystroglycanopathy]. Kuga A; Kanagawa M; Toda T Brain Nerve; 2011 Nov; 63(11):1189-95. PubMed ID: 22068471 [TBL] [Abstract][Full Text] [Related]